Results 241 to 250 of about 38,244 (308)
Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis‐endemic setting
HemaSphere, Volume 10, Issue 6, June 2026.Abstract
In HIV‐ and tuberculosis (TB)‐endemic regions, lymphoma diagnosis is often delayed because symptoms can overlap with TB, and access to biopsy and specialized pathology is limited. To address this, we developed and internally evaluated the Access to Diagnosis using Liquid Biopsy (ADLiB) platform—a plasma cell‐free DNA (cfDNA)‐based approach ...Katherine Antel, Nina Xiong, Mwanasha Merrill, Taiyang Chen, Lauren McGrath, Clara Droessler, Maxine van der Schyff, Meng‐Xuan Wu, Dylan Cheddie, Charlotte Slome, Liam McBride, Jonathan Day, Zainab Mohamed, Nazia Fakie, Nomonde Mbatani, Charlotte Shultz, Graeme Meintjes, Svitlana Tyekucheva, Elizabeth F. Cohen, Michael Y. Tolstorukov, Estelle Verburgh, Mark A. Murakami +21 morewiley +1 more sourceTechnical feasibility of a long read, fourth generation sequencing platform in diagnostic profiling of clinical routine samples: a proof-of-concept study. [PDF]
PathologicaVitale D, Colarossi L, Russo G, Scimone C, Cozzolino D, De Luca C, Prjibelski AD, Mikheenko A, Colarossi C, Delli Muti F, Pepe F, Memeo L, Troncone G, Muscarella LA, Malapelle U. +14 moreeuropepmc +1 more sourceUpdate of the MSKCC nomogram for metastatic progression and its role in active surveillance: the Italian TPCP cohort. [PDF]
Front OncolDestefanis N, Zugna D, Fiano V, Zelic R, Fiorentino M, Giunchi F, Fariselli P, Papotti MG, Cassoni P, Oderda M, Gontero P, Lianas L, Del Rio M, Iorio GC, Ricardi U, Akre O, Pettersson A, Richiardi L. +17 moreeuropepmc +1 more sourceValidation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study. [PDF]
Blood NeoplasiaBarragán E, Gil JV, Ayala R, Chillón C, Soria E, Bilbao C, Larráyoz MJ, Prados de la Torre E, Solana A, Martínez-Cuadrón D, Rodríguez-Veiga R, Rodríguez-Arbolí E, Tormo M, Martínez P, Lavilla E, García-Garay MC, Arce O, Bergua J, Serrano J, Botella C, Lacalzada C, Almela-Gallego A, Lopez-Lorenzo JL, Valero M, Ibañez F, Foncillas MÁ, Rodriguez-Medina C, Olave M, Gómez-Correcha KG, Calderón MT, Bernal T, Labrador J, Oliva A, Madrigal MD, Hermosín L, Amador L, García-Belmonte D, Herrera P, Vives S, Perez-Encinas M, Algarra L, Casado S, Martínez-Chamorro C, Polo M, Balerdi A, Roldán A, Couto C, Pereiro M, Vanegas R, Llop M, Sargas C, Cionfrini A, Mendizábal Y, Sánchez J, Calasanz MJ, Gómez-Casares MT, Pérez-Simón JA, García-Sanz R, Martínez-López J, Montesinos P, PETHEMA group. +60 moreeuropepmc +1 more sourceMissing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care. [PDF]
Kidney Int RepDe Nicola L, Ruotolo C, La Manna G, Bellizzi V, Gesualdo L, Nappi F, Ferraro PM, Marcantoni C, Santoro D, Stallone G, Pisani A, Abaterusso C, Cupisti A, Vernaglione L, Ravera M, Cozzolino M, Gallieni M, Alberici F, Corvinelli M, Battaglia Y, Capitanini A, Aucella F, Castellano G, Simeoni M, Provenzano M, Bonomini M, Reboldi G, Ferrantelli A, Esposito C, Cabiddu G, Grandaliano G, Minutolo R, REport of Nondialysis patients followed-up with in Italian nephrology clinics to Enable Winning strategy in CKD (RENEW-CKD) study group of Italian Society of Nephrology. +32 moreeuropepmc +1 more sourceInfants exposed to maternal type 1 diabetes: intrauterine epigenetic modifications and neurological development. [PDF]
Front Endocrinol (Lausanne)González-González NL, González-Dávila E, Castro-Conde JR, González-Campos C, Orribo-Morales O, Flores C, Lorenzo-Salazar JM, González-Montelongo R, Muñoz-Barrera A, Padrón-Pérez E, Villalba-Martín N, Acevedo-Arozena A, Tascón-Padrón L, Armas-González M. +13 moreeuropepmc +1 more source